Literature DB >> 26116089

Analysis of the Effect of Race, Socioeconomic Status, and Center Size on Unrelated National Marrow Donor Program Donor Outcomes: Donor Toxicities Are More Common at Low-Volume Bone Marrow Collection Centers.

Bronwen E Shaw1, Brent R Logan2, Deidre M Kiefer3, Pintip Chitphakdithai3, Tanya L Pedersen4, Hisham Abdel-Azim5, Muneer H Abidi6, Gorgun Akpek7, Miguel A Diaz8, Andrew S Artz9, Christopher Dandoy10, James L Gajewski11, Peiman Hematti12, Rammurti T Kamble13, Kimberley A Kasow14, Hillard M Lazarus15, Jane L Liesveld16, Navneet S Majhail17, Paul V O'Donnell18, Richard F Olsson19, Bipin N Savani20, Raquel M Schears21, David F Stroncek22, Galen E Switzer23, Eric P Williams24, John R Wingard25, Baldeep M Wirk26, Dennis L Confer24, Michael A Pulsipher27.   

Abstract

Previous studies have shown that risks of collection-related pain and symptoms are associated with sex, body mass index, and age in unrelated donors undergoing collection at National Marrow Donor Program centers. We hypothesized that other important factors (race, socioeconomic status [SES], and number of procedures at the collection center) might affect symptoms in donors. We assessed outcomes in 2726 bone marrow (BM) and 6768 peripheral blood stem cell (PBSC) donors collected between 2004 and 2009. Pain/symptoms are reported as maximum levels over mobilization and collection (PBSC) or within 2 days of collection (BM) and at 1 week after collection. For PBSC donors, race and center volumes were not associated with differences in pain/symptoms at any time. PBSC donors with high SES levels reported higher maximum symptom levels 1 week after donation (P = .017). For BM donors, black males reported significantly higher levels of pain (OR, 1.90; CI, 1.14 to 3.19; P = .015). No differences were noted by SES group. BM donors from low-volume centers reported more toxicity (OR, 2.09; CI, 1.26 to 3.46; P = .006). In conclusion, race and SES have a minimal effect on donation-associated symptoms. However, donors from centers performing ≤ 1 BM collection every 2 months have more symptoms after BM donation. Approaches should be developed by registries and low-volume centers to address this issue.
Copyright © 2015 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone marrow; Donor center; Donor toxicities; PBSC; Race; Socioeconomic status; Unrelated donor

Mesh:

Substances:

Year:  2015        PMID: 26116089      PMCID: PMC4568129          DOI: 10.1016/j.bbmt.2015.06.013

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  25 in total

1.  Ethnic similarities and differences in the chronic pain experience: a comparison of african american, Hispanic, and white patients.

Authors:  Robert R Edwards; Mario Moric; Brenda Husfeldt; Asokumar Buvanendran; Olga Ivankovich
Journal:  Pain Med       Date:  2005 Jan-Feb       Impact factor: 3.750

2.  Peripheral blood stem cell mobilization and apheresis: analysis of adverse events in 94 normal donors.

Authors:  M Murata; M Harada; S Kato; S Takahashi; H Ogawa; S Okamoto; S Tsuchiya; H Sakamaki; Y Akiyama; Y Kodera
Journal:  Bone Marrow Transplant       Date:  1999-11       Impact factor: 5.483

3.  Collection of autologous blood for bone marrow donation: how useful is it?

Authors:  T Parkkali; E Juvonen; L Volin; J Partanen; T Ruutu
Journal:  Bone Marrow Transplant       Date:  2005-06       Impact factor: 5.483

4.  Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells.

Authors:  D F Stroncek; M E Clay; M L Petzoldt; J Smith; W Jaszcz; F B Oldham; J McCullough
Journal:  Transfusion       Date:  1996-07       Impact factor: 3.157

5.  Ethnic identity predicts experimental pain sensitivity in African Americans and Hispanics.

Authors:  F Bridgett Rahim-Williams; Joseph L Riley; Dyanne Herrera; Claudia M Campbell; Barbara A Hastie; Roger B Fillingim
Journal:  Pain       Date:  2007-02-12       Impact factor: 6.961

6.  Health-related quality of life of unrelated bone marrow donors in Japan.

Authors:  Mina Nishimori; Yoshitsugu Yamada; Keiko Hoshi; Yuichi Akiyama; Yasutaka Hoshi; Yasuo Morishima; Masahiro Tsuchida; Shunichi Fukuhara; Yoshihisa Kodera
Journal:  Blood       Date:  2002-03-15       Impact factor: 22.113

7.  Optimizing BM harvesting from normal adult donors.

Authors:  H Lannert; T Able; S Becker; M Sommer; M Braun; P Stadtherr; A D Ho
Journal:  Bone Marrow Transplant       Date:  2008-07-14       Impact factor: 5.483

8.  Preoperative autologous blood donation for bone marrow harvests: are we wasting donors' time and blood?

Authors:  A Mijovic; C Britten; F Regan; J Harrison
Journal:  Transfus Med       Date:  2006-02       Impact factor: 2.019

9.  Correlation between characteristics of unrelated bone marrow donor and cell density of total nucleated cell in bone marrow harvest.

Authors:  Ruey-Ho Kao; Chi-Cheng Li; Cheng-Kuang Shaw; Tso-Fu Wang; Sung-Chao Chu; Shu-Huey Chen; Chao-Yuan Yao; Kuan-Po Huang; Yi-Feng Wu
Journal:  Int J Hematol       Date:  2009-01-08       Impact factor: 2.490

Review 10.  Recovery and safety profiles of marrow and PBSC donors: experience of the National Marrow Donor Program.

Authors:  John P Miller; Elizabeth H Perry; Thomas H Price; Charles D Bolan; Chatchada Karanes; Theresa M Boyd; Pintip Chitphakdithai; Roberta J King
Journal:  Biol Blood Marrow Transplant       Date:  2008-09       Impact factor: 5.742

View more
  4 in total

1.  The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time.

Authors:  Nicole L Prokopishyn; Brent R Logan; Deidre M Kiefer; Jennifer A Sees; Pintip Chitphakdithai; Ibrahim A Ahmed; Paolo N Anderlini; Amer M Beitinjaneh; Christopher Bredeson; Jan Cerny; Saurabh Chhabra; Andrew Daly; Miguel Angel Diaz; Nosha Farhadfar; Haydar A Frangoul; Siddhartha Ganguly; Dennis A Gastineau; Usama Gergis; Gregory A Hale; Peiman Hematti; Rammurti T Kamble; Kimberly A Kasow; Hillard M Lazarus; Jane L Liesveld; Hemant S Murthy; Maxim Norkin; Richard F Olsson; Mona Papari; Bipin N Savani; Jeffrey Szer; Edmund K Waller; Baldeep Wirk; Jean A Yared; Michael A Pulsipher; Nirali N Shah; Galen E Switzer; Paul V O'Donnell; Dennis L Confer; Bronwen E Shaw
Journal:  Biol Blood Marrow Transplant       Date:  2019-02-02       Impact factor: 5.742

2.  Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase III Blood and Marrow Transplant Clinical Trials Network Protocol 0201.

Authors:  Linda J Burns; Brent R Logan; Pintip Chitphakdithai; John P Miller; Rebecca Drexler; Stephen Spellman; Galen E Switzer; John R Wingard; Claudio Anasetti; Dennis L Confer
Journal:  Biol Blood Marrow Transplant       Date:  2016-03-21       Impact factor: 5.742

3.  Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States.

Authors:  Sanghee Hong; Ruta Brazauskas; Kyle M Hebert; Siddhartha Ganguly; Hisham Abdel-Azim; Miguel Angel Diaz; Sara Beattie; Stefan O Ciurea; David Szwajcer; Sherif M Badawy; Alois A Gratwohl; Charles LeMaistre; Mahmoud D S M Aljurf; Richard F Olsson; Neel S Bhatt; Nosha Farhadfar; Jean A Yared; Ayami Yoshimi; Sachiko Seo; Usama Gergis; Amer M Beitinjaneh; Akshay Sharma; Hillard Lazarus; Jason Law; Matthew Ulrickson; Hasan Hashem; Hélène Schoemans; Jan Cerny; David Rizzieri; Bipin N Savani; Rammurti T Kamble; Bronwen E Shaw; Nandita Khera; William A Wood; Shahrukh Hashmi; Theresa Hahn; Stephanie J Lee; J Douglas Rizzo; Navneet S Majhail; Wael Saber
Journal:  Cancer       Date:  2020-10-21       Impact factor: 6.860

Review 4.  Clinical Trial Accrual: Obstacles and Opportunities.

Authors:  B J Rimel
Journal:  Front Oncol       Date:  2016-04-25       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.